Clinical Trial: Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse

U.S., Oct. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07871864) titled 'Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse' on Sept. 16.

Brief Summary: This clinical study is the initiative of the FOSTER (Fight OsteoSarcoma Through European Research) consortium and Gustave Roussy, which is the sponsor. Its aim is to evaluate the biology of tumour in greater depth by collecting samples of the tumour during the biopsy at diagnosis, and blood samples. This study is a platform study that evolves over time. This means that it allows for the evaluation of several treatments or therapeutic strategies within a single clinical trial, which can be modified and adapted o...